Tag Archives: biotechnology

European Investment Bank funds new BioSense Institute building in Novi Sad for scientific research and startups

(IN BRIEF) The BioSense Institute in Novi Sad has opened a new building offering modern facilities for scientific research and business ventures in the fields of agriculture and biotechnology. The €34 million project was financed by €14 million in EU … Read the full press release

Patients as Partners Europe Returns to London and Announces Agenda Highlights

(IN BRIEF) The Conference Forum has announced that the 7th annual European Patients as Partners® in Clinical Research conference will take place in London on June 12-13, 2023. The event will focus on achieving greater representation in clinical research, building … Read the full press release

Bayer awards grants and mentorship to innovative agriculture researchers

(IN BRIEF) Bayer has announced the recipients of its 2023 Grants4Ag program, which will provide funding and mentorship to researchers working on sustainability and biotechnology in agriculture. The program will award grants ranging from €5,000 to €15,000 and connect researchers … Read the full press release

New research challenges accepted mechanism for creating electropores in biomembranes

(IN BRIEF) Researchers from the Ecole Normale Supérieure in Lyon and the University of Freiburg’s Institute of Physiology have cast doubt on the accepted model of creating electropores in biomembranes using electric fields. Electroporation is used to create targeted defects … Read the full press release

UKRI Launches Biotech Business Incubation Centre to Boost Start-ups

(IN BRIEF) UK Research and Innovation has launched the Biotech Business Incubation Centre (Bio BIC) in the north-west of England to support small biotech businesses. Bio BIC, a collaboration between the Biotechnology and Biological Sciences Research Council and the Science … Read the full press release

Tony Wood to succeed Dr Hal Barron as Chief Scientific Officer at GlaxoSmithKline R&D

Tony Wood to assume full accountability for GSK R&D in August 2022 Hal Barron to transition in August 2022 from CSO to a GSK Non-Executive Director with additional responsibilities to support R&D (PRESS RELEASE) LONDON, 19-Jan-2022 — /EuropaWire/ — GlaxoSmithKline … Read the full press release

Sanofi adds first vaccine candidate against acne to its R&D pipeline with the take over of an Austrian privately held biotechnology firm

Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorders Transaction adds to Sanofi pipeline a potential first-in-class vaccine candidate in acne vulgaris, a condition affecting millions of people worldwide Sanofi to leverage its next-generation mRNA platform to unlock … Read the full press release

Kuehne+Nagel takes responsibility of global distribution of Covid-19 Vaccine Moderna

New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics (PRESS RELEASE) CAMBRIDGE, MA, U.S.A. / SCHINDELLEGI, 7-Jan-2021 — /EuropaWire/ — Global transport and logistics company Kuehne+Nagel announces international supply chain arrangement with Moderna, Inc. (NASDAQ:MRNA), a biotechnology company … Read the full press release

Novozymes welcomes new Executive Vice President of People, Sustainability & Brand Morten Enggaard Rasmussen

(PRESS RELEASE) COPENHAGEN, 26-Nov-2020 — /EuropaWire/ — Global biotechnology company Novozymes announces the appointment of Morten Enggaard Rasmussen as Executive Vice President of People, Sustainability & Brand succeeding Thomas Videbæk. Morten will take up his new position on 1 April, … Read the full press release

Eveliqure announces the initiation of a Phase 1 clinical study of its combined Shigella and ETEC vaccine candidate

(PRESS RELEASE) VIENNA, 24-Sep-2020 — /EuropaWire/ — Eveliqure Biotechnologies GmbH, an Austrian biotechnology company, today announces the initiation of clinical testing for its ShigETEC vaccine candidate, with the dosing of the first subject in a Phase 1 safety and immunogenicity … Read the full press release

Shire: U.S. FDA approval makes CINRYZE® available to help prevent angioedema attacks in children with hereditary angioedema

CINRYZE is the first and only therapy indicated in the U.S. to help prevent angioedema attacks in pediatric patients with hereditary angioedema (HAE) as young as 6 Shire is the only drug developer to complete a pediatric study for the … Read the full press release

U.S. FDA approval for Shire’s first submission for its new plasma manufacturing facility near Covington, Georgia

New facility will add 30% capacity to Shire’s internal plasma manufacturing network once fully operational Expanded capacity supports continued strong growth of Shire’s leading immunoglobulin portfolio and further strengthens ability to deliver complex therapies for rare immune-mediated conditions DUBLIN, 25-Jun-2018 … Read the full press release

EBRD takes part in the US$ 51 million private placement of Mabion S.A.

Participation in private placement as a cornerstone investor EBRD participates in US$ 51m equivalent private placement of Mabion Mabion is leading biotechnology company in Poland EBRD to invest US$ 18 million (PLN 61.4 million) LONDON, 26-Mar-2018 — /EuropaWire/ — The EBRD … Read the full press release

University of Warwick: biotechnology firm VirionHealth receives non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA)

Coventry, UK, 08-Jan-2018 — /EuropaWire/ — VirionHealth Ltd, a new biotechnology company developing novel therapeutics for respiratory viral infections, today announced that it has won non-dilutive funding worth up to $4.2 million from the US Defense Advanced Research Projects Agency (DARPA). … Read the full press release

VivaCell Spain and Aphios USA to develop novel class of compounds for Multiple sclerosis and CNS disorders

Cordoba, Spain, 12-6-2013 — /europawire.eu/ — VivaCell Biotechnology España S.L., Cordoba, Spain today announced that it has entered into joint Research Collaboration and Commercialization Agreements with Aphios Corporation, USA, to develop therapeutics for multiple sclerosis and other neurodegenerative diseases of the central … Read the full press release

Bayer Science & Education Foundation launches new round of funding – Applications now possible online till July 15, 2013

Bayer foundation scholarships – EUR 200,000 for work and study abroad Support for ambitious study projects in the fields of science, engineering, medicine and teacher training in scientific subjects / Hermann Strenger scholarships to sponsor career-training projects abroad  Leverkusen, 5-6-2013 … Read the full press release

EIB injects EUR 150m into Gedeon Richter’s R&D operations in Hungary, one of the biggest research projects in central Europe

We are supporting research and development into innovative drug treatments in Hungary 7-5-2013 — /europawire.eu/ — For well over 100 years, Hungarian pharmaceutical company Gedeon Richter has been working to improve their clients’ health and quality of life. It has stepped … Read the full press release